跳至主要内容
临床试验/EUCTR2011-004417-16-NL
EUCTR2011-004417-16-NL进行中(未招募)1 期

CEFTRIAXONE NEONATAL THERAPY: A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF CEFTRIAXONE ON HYPERBILIRUBINEMIA - CEFSINT

St. Elisabeth Hospital0 个研究点开始时间: 2012年6月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All neonates, 0-28 days old, with a gestational age (GA) of = 34 weeks, admitted to the neonatal unit and requiring antibiotic treatment for a serious bacterial infection
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 150
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Gestational age <34 weeks; congenital malformations; erythrocyte transfusion; blood group or other types of antibody antagonism; haemoglobinopathy; malignancy; serious perinatal asphyxia ; concomitant use of intravenous calcium containing solutions (intravenous fluid or total parenteral nutrition) or transfer to another hospital before completion of study.

研究者

发起方
St. Elisabeth Hospital

相似试验